The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports


News Update

Biotech in Neuro Diseases Adds Parkinson's Expert to Scientific Advisory Board

News Update
  ()
The expert brings to the board a deep knowledge of neurodegeneration. read more >

Biotech Reports 'Eye-Catching, Topline Results' from RSV Vaccine Study

Research Report
  ()
The data and how the asset stacks up to others were covered in a ROTH Capital Partners report. read more >

Precision Medicine Firm Announces 'Positive' Data in Lymphoma Study

Research Report
  ()
The highlights of the results were presented in an H.C. Wainwright & Co. report. read more >
News Update

Biopharma Advances Dose Escalation Trial in Alcoholic Hepatitis

News Update
  ()
The company received approval to proceed with the next and final dose level. read more >

Interim Results Put Biopharma with Tenbagger Potential 'Back on the Map'

Research Report
  ()
A key upcoming catalyst and the impact of recent positive trial results are addressed in a ROTH Capital Partners report. read more >
News Update

Biotech to Present Alzheimer's Disease Therapeutic at Keystone Symposium

News Update
  ()
The focus will be the Canadian company's lead monoclonal antibody candidate. read more >

Coverage Initiated on Biotech Whose Therapies 'Can Compete with CAR-Ts'

Research Report
  ()
The reasons for the Buy rating on the U.K. firm are delineated in a ROTH Capital Partners report. read more >

Biopharma Receives FDA Fast Track Designation for Cancer Therapeutic

Research Report
  ()
An explanation of the categorization and its implications are provided in a Paradigm Capital report. read more >

Biopharma's LDL Cholesterol-Lowering Drug Emerges as 'Lead Stallion in Safety'

Research Report
  ()
The interim study results for an in-progress trial evaluating this asset are discussed in a ROTH Capital Partners report. read more >
News Update

Biotech Identifies Antibodies for Toxic Tau in Alzheimer's Disease

News Update
  ()
The Canadian company's approach to this indication is now twofold. read more >

California-Based Biopharma Signs Licensing Deal for Acquired Asset

Research Report
  ()
The transaction details and the drug platform's potential are addressed in an H.C. Wainwright & Co. report. read more >

Immuno-oncology Firm to Co-Develop Companion Diagnostic for Cervical Dysplasia

Research Report
  ()
The partnership news and upcoming data readouts are reviewed in an H.C. Wainwright & Co. report. read more >

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

Research Report
  ()
The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report. read more >

U.S. Biopharma's 'Biggest Stock Moving Event' Imminent

Research Report
  ()
With study results from this company due out shortly, an analysis of the possible outcomes was provided in a ROTH Capital Partners report. read more >

Cancer Fighter Sesen Bio Leaps 13% on FDA Decision

  ()
Shares of this biotech stock were up significantly at the close of trading on Tuesday, May 21, attributed to the announcement of some good news from the FDA. read more >

Harrow Comes Out of Allergan Lawsuit Unscathed

Contributed Opinion
  ()
Sector expert Daniel Carlson offers his take on the recent jury decision, calling it "very positive." read more >

Why Did ImmunoGen Plummet 32%?

  ()
This biotechnology company, which focuses on the treatment of cancer, received some feedback from the FDA that upset investors on Wednesday. read more >

FDA Approval of Antibiotic for Bacterial Pneumonia Expected in Late Summer

Research Report
  ()
An update on this biopharma's two lead drug candidate programs was provided in an H.C. Wainwright report. read more >
News Update

Biopharma Releases Preliminary Data from Alcoholic Hepatitis Study

News Update
  ()
The results compare favorably to those of the historical control group. read more >

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million

Research Report
  ()
The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report. read more >

Price Target Raised on Biopharma Ahead of Leukemia Trial Update

Research Report
  ()
The expected data and their implications were addressed in a ROTH Capital Partners report. read more >

'Pivotal Topline Up Next' for Biotech's Phase 3 Cardiac Clinical Trial

Research Report
  ()
A study update and the next steps to advance the therapeutic were covered in a ROTH Capital Partners report. read more >

Immuno-Oncology Firm to Collaborate on Third Clinical Trial with Genentech

Research Report
  ()
Descriptions of the new study and upcoming data readouts for this California-based firm were provided in an H.C. Wainwright & Co. report. read more >
News Update

Firm's AR E-Commerce Solutions to Be Marketed, Sold to Dispensaries

News Update
  ()
With the signing of a reseller agreement, the tech firm continues to penetrate Canada's burgeoning legal cannabis industry. read more >

'Undervalued' Biopharma Features Robust Pipeline, Future Upside

Research Report
  ()
The case for investing in this company was made in an H.C. Wainwright & Co. report. read more >
Showing Results: 1 to 25 of 75 Next

Get Our Streetwise Reports Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"LIO began drilling at Tuvatu, initially focusing on the HT corridor." ❭
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"SEA entered an agreement to acquire the Goldstorm project in Nevada." ❭
– Mike Kozak, Cantor Fitzgerald
"Drilling at PVG's Flow Dome extended mineralization 240m to the east." ❭
– Andrew Kaip, BMO Capital Markets
"GSV has now completed its 2019 phase 1 drill program at Dark Star." ❭
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"AUAU's Eastside asset has value, to be sure." ❭
– Gwen Preston, Resource Maven